ATE509271T1 - Verfahren zur diagnose von myasthenia gravis - Google Patents

Verfahren zur diagnose von myasthenia gravis

Info

Publication number
ATE509271T1
ATE509271T1 AT06290012T AT06290012T ATE509271T1 AT E509271 T1 ATE509271 T1 AT E509271T1 AT 06290012 T AT06290012 T AT 06290012T AT 06290012 T AT06290012 T AT 06290012T AT E509271 T1 ATE509271 T1 AT E509271T1
Authority
AT
Austria
Prior art keywords
myasthenia gravis
heat
shock protein
diagnosis
subject
Prior art date
Application number
AT06290012T
Other languages
English (en)
Inventor
Tzu-Ling Tseng
Pei-Hsiu Liao
Ping-Fu Cheng
Shih-Feng Tsai
Hou-Chang Chiu
Original Assignee
Ind Tech Res Inst
Nat Health Research Institutes
Shin Kong Wu Ho Su Memorial Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst, Nat Health Research Institutes, Shin Kong Wu Ho Su Memorial Hospital filed Critical Ind Tech Res Inst
Application granted granted Critical
Publication of ATE509271T1 publication Critical patent/ATE509271T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AT06290012T 2006-01-04 2006-01-04 Verfahren zur diagnose von myasthenia gravis ATE509271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06290012A EP1806582B1 (de) 2006-01-04 2006-01-04 Verfahren zur Diagnose von Myasthenia gravis

Publications (1)

Publication Number Publication Date
ATE509271T1 true ATE509271T1 (de) 2011-05-15

Family

ID=36603619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06290012T ATE509271T1 (de) 2006-01-04 2006-01-04 Verfahren zur diagnose von myasthenia gravis

Country Status (2)

Country Link
EP (1) EP1806582B1 (de)
AT (1) ATE509271T1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5995770B2 (ja) 2013-03-29 2016-09-21 三菱重工業株式会社 ガス内燃機関の排気パージ装置
US11235040B2 (en) 2014-09-15 2022-02-01 The Trustees Of The University Of Pennsylvania Acetylcholine receptor-specific immunosuppressive compositions and methods of treatment of myasthenia gravis
CN117388494A (zh) * 2023-10-08 2024-01-12 烟台普罗吉生物科技发展有限公司 一种肿瘤标志物在肿瘤诊断及肿瘤治疗监测产品中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2270076A (en) * 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
JP4269064B2 (ja) * 2003-02-26 2009-05-27 国立大学法人 千葉大学 重症筋無力症の検査方法及びそのための検査薬
US20050260770A1 (en) * 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof

Also Published As

Publication number Publication date
EP1806582A1 (de) 2007-07-11
EP1806582B1 (de) 2011-05-11

Similar Documents

Publication Publication Date Title
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
WO2009152607A8 (en) Methods and kits for diagnosing neurodegenerative disease
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
GB0510511D0 (en) Diagnosis of tuberculosis
WO2007117444A3 (en) Protein detection by aptamers
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
GB0510943D0 (en) Improved immunoassay methods
EA201290629A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
JP2011516038A5 (de)
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
JP2013539032A5 (de)
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
SI3171174T1 (en) Lactoferrin for use in the diagnosis or prognosis of Alzheimer's disease
EP3287789A1 (de) Zusammensetzung und kit zur diagnose von verhaltenssucht und verfahren zur erkennung von neuropilin-2 zur diagnose von verhaltenssucht
ATE509271T1 (de) Verfahren zur diagnose von myasthenia gravis
ATE553127T1 (de) Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits
ATE406579T1 (de) Verfahren zur diagnose von tumoren
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties